Reuters logo
US FDA panel backs Medtronic drug-coated stent
October 10, 2007 / 9:27 PM / 10 years ago

US FDA panel backs Medtronic drug-coated stent

WASHINGTON, Oct 10 (Reuters) - Medtronic Inc’s (MDT.N) drug-coated Endeavor heart stent should be approved, a U.S. advisory panel unanimously said on Wednesday.

The Food and Drug Administration usually follows panel recommendations. Medtronic expects a final FDA ruling by year-end. (Reporting by Lisa Richwine)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below